Utah Medical Products Inc (UTMD)
69.70
+1.78
(+2.62%)
USD |
NASDAQ |
May 06, 16:00
69.72
+0.02
(+0.03%)
After-Hours: 20:00
Utah Medical Products Price to Book Value: 1.958 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 1.958 |
| May 03, 2024 | 1.908 |
| May 02, 2024 | 1.890 |
| May 01, 2024 | 1.906 |
| April 30, 2024 | 1.860 |
| April 29, 2024 | 1.862 |
| April 26, 2024 | 1.852 |
| April 25, 2024 | 1.862 |
| April 24, 2024 | 1.886 |
| April 23, 2024 | 1.898 |
| April 22, 2024 | 1.914 |
| April 19, 2024 | 1.926 |
| April 18, 2024 | 1.888 |
| April 17, 2024 | 1.900 |
| April 16, 2024 | 1.914 |
| April 15, 2024 | 1.920 |
| April 12, 2024 | 1.929 |
| April 11, 2024 | 1.971 |
| April 10, 2024 | 1.97 |
| April 09, 2024 | 1.994 |
| April 08, 2024 | 1.966 |
| April 05, 2024 | 1.940 |
| April 04, 2024 | 1.926 |
| April 03, 2024 | 1.928 |
| April 02, 2024 | 1.949 |
| Date | Value |
|---|---|
| April 01, 2024 | 1.987 |
| March 31, 2024 | |
| March 28, 2024 | 1.989 |
| March 27, 2024 | 1.963 |
| March 26, 2024 | 1.906 |
| March 25, 2024 | 1.940 |
| March 22, 2024 | 1.930 |
| March 21, 2024 | 1.929 |
| March 20, 2024 | 1.973 |
| March 19, 2024 | 1.939 |
| March 18, 2024 | 1.932 |
| March 15, 2024 | 1.950 |
| March 14, 2024 | 1.960 |
| March 13, 2024 | 1.977 |
| March 12, 2024 | 2.011 |
| March 11, 2024 | 1.964 |
| March 08, 2024 | 1.951 |
| March 07, 2024 | 1.964 |
| March 06, 2024 | 1.951 |
| March 05, 2024 | 1.979 |
| March 04, 2024 | 2.006 |
| March 01, 2024 | 1.961 |
| February 29, 2024 | 1.985 |
| February 28, 2024 | 1.978 |
| February 27, 2024 | 1.984 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.852
Minimum
Apr 26 2024
4.282
Maximum
Dec 19 2019
3.066
Average
3.044
Median
Mar 18 2022
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 14.29 |
| Retractable Technologies Inc | 0.3294 |
| Xtant Medical Holdings Inc | 2.232 |
| Asensus Surgical Inc | 1.983 |
| Catheter Precision Inc | 0.1969 |
Price to Book Value Related Metrics
| PE Ratio | 15.48 |
| PS Ratio | 5.163 |
| Price | 69.70 |
| Earnings Yield | 6.46% |
| Market Cap | 250.10M |
| Operating PE Ratio | 15.61 |
| Normalized PE Ratio | 15.48 |